Expert Interview
Examining the topline results from the Phase 2b FRONTIER 1 clinical trial of Johnson & Johnson's JNJ-2113 in patients with Plaque Psoriasis.
Ticker(s): JNJ, ABBVInstitution: Boston University
- Director of the Boston University Cosmetic and Laser Center, Founding Director of the Boston University Center for Ethnic Skin, and an Associate Professor of Dermatology at the Boston University School of Medicine.
- Manages 500 patients with plaque psoriasis.
- Widely published in peer-reviewed literature, and recipient of the Presidential Citation Award from the American Academy of Dermatology.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
